Bank of New York Mellon’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $39K | Hold |
29,293
| – | – | ﹤0.01% | 4074 |
|
2025
Q1 | $34.9K | Sell |
29,293
-2
| -0% | -$2 | ﹤0.01% | 4048 |
|
2024
Q4 | $47.8K | Hold |
29,295
| – | – | ﹤0.01% | 4054 |
|
2024
Q3 | $112K | Hold |
29,295
| – | – | ﹤0.01% | 3989 |
|
2024
Q2 | $85.8K | Sell |
29,295
-69,555
| -70% | -$204K | ﹤0.01% | 4032 |
|
2024
Q1 | $391K | Sell |
98,850
-8,892
| -8% | -$35.2K | ﹤0.01% | 3657 |
|
2023
Q4 | $535K | Sell |
107,742
-1,084
| -1% | -$5.39K | ﹤0.01% | 3510 |
|
2023
Q3 | $550K | Sell |
108,826
-745
| -0.7% | -$3.76K | ﹤0.01% | 3493 |
|
2023
Q2 | $551K | Buy |
109,571
+66,039
| +152% | +$332K | ﹤0.01% | 3524 |
|
2023
Q1 | $268K | Sell |
43,532
-19,849
| -31% | -$122K | ﹤0.01% | 3793 |
|
2022
Q4 | $837K | Buy |
63,381
+25,231
| +66% | +$333K | ﹤0.01% | 3279 |
|
2022
Q3 | $113K | Hold |
38,150
| – | – | ﹤0.01% | 4172 |
|
2022
Q2 | $139K | Sell |
38,150
-607
| -2% | -$2.21K | ﹤0.01% | 4161 |
|
2022
Q1 | $240K | Hold |
38,757
| – | – | ﹤0.01% | 4142 |
|
2021
Q4 | $314K | Hold |
38,757
| – | – | ﹤0.01% | 4067 |
|
2021
Q3 | $577K | Hold |
38,757
| – | – | ﹤0.01% | 3723 |
|
2021
Q2 | $486K | Buy |
38,757
+4,856
| +14% | +$60.9K | ﹤0.01% | 3781 |
|
2021
Q1 | $154K | Sell |
33,901
-2,463
| -7% | -$11.2K | ﹤0.01% | 4104 |
|
2020
Q4 | $78K | Hold |
36,364
| – | – | ﹤0.01% | 4108 |
|
2020
Q3 | $85K | Hold |
36,364
| – | – | ﹤0.01% | 3973 |
|
2020
Q2 | $73K | Sell |
36,364
-1
| -0% | -$2 | ﹤0.01% | 3934 |
|
2020
Q1 | $26K | Buy |
+36,365
| New | +$26K | ﹤0.01% | 4031 |
|
2019
Q1 | – | Sell |
-780
| Closed | -$5K | – | 4225 |
|
2018
Q4 | $5K | Hold |
780
| – | – | ﹤0.01% | 4208 |
|
2018
Q3 | $13K | Hold |
780
| – | – | ﹤0.01% | 4213 |
|
2018
Q2 | $16K | Sell |
780
-2,933
| -79% | -$60.2K | ﹤0.01% | 4176 |
|
2018
Q1 | $88K | Buy |
3,713
+833
| +29% | +$19.7K | ﹤0.01% | 4071 |
|
2017
Q4 | $540K | Sell |
2,880
-9
| -0.3% | -$1.69K | ﹤0.01% | 3581 |
|
2017
Q3 | $620K | Sell |
2,889
-6
| -0.2% | -$1.29K | ﹤0.01% | 3475 |
|
2017
Q2 | $594K | Sell |
2,895
-164
| -5% | -$33.7K | ﹤0.01% | 3524 |
|
2017
Q1 | $557K | Buy |
3,059
+5
| +0.2% | +$910 | ﹤0.01% | 3510 |
|
2016
Q4 | $764K | Buy |
3,054
+466
| +18% | +$117K | ﹤0.01% | 3407 |
|
2016
Q3 | $539K | Buy |
2,588
+324
| +14% | +$67.5K | ﹤0.01% | 3499 |
|
2016
Q2 | $457K | Buy |
2,264
+1,147
| +103% | +$232K | ﹤0.01% | 3583 |
|
2016
Q1 | $204K | Buy |
1,117
+155
| +16% | +$28.3K | ﹤0.01% | 3781 |
|
2015
Q4 | $240K | Buy |
+962
| New | +$240K | ﹤0.01% | 3791 |
|